These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21801975)

  • 21. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Rabkin SW; McAlister FA; Bell CM; Touyz RM; Padwal R; Leiter LA; Mahon JL; Hill MD; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Arnold MO; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; dechamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Katzmarzyk P; Tobe S; Lewanczuk RZ;
    Can J Cardiol; 2008 Jun; 24(6):465-75. PubMed ID: 18548143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
    Hackam DG; Quinn RR; Ravani P; Rabi DM; Dasgupta K; Daskalopoulou SS; Khan NA; Herman RJ; Bacon SL; Cloutier L; Dawes M; Rabkin SW; Gilbert RE; Ruzicka M; McKay DW; Campbell TS; Grover S; Honos G; Schiffrin EL; Bolli P; Wilson TW; Feldman RD; Lindsay P; Hill MD; Gelfer M; Burns KD; Vallée M; Prasad GV; Lebel M; McLean D; Arnold JM; Moe GW; Howlett JG; Boulanger JM; Larochelle P; Leiter LA; Jones C; Ogilvie RI; Woo V; Kaczorowski J; Trudeau L; Petrella RJ; Milot A; Stone JA; Drouin D; Lavoie KL; Lamarre-Cliche M; Godwin M; Tremblay G; Hamet P; Fodor G; Carruthers SG; Pylypchuk GB; Burgess E; Lewanczuk R; Dresser GK; Penner SB; Hegele RA; McFarlane PA; Sharma M; Reid DJ; Tobe SW; Poirier L; Padwal RS;
    Can J Cardiol; 2013 May; 29(5):528-42. PubMed ID: 23541660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
    Dasgupta K; Quinn RR; Zarnke KB; Rabi DM; Ravani P; Daskalopoulou SS; Rabkin SW; Trudeau L; Feldman RD; Cloutier L; Prebtani A; Herman RJ; Bacon SL; Gilbert RE; Ruzicka M; McKay DW; Campbell TS; Grover S; Honos G; Schiffrin EL; Bolli P; Wilson TW; Lindsay P; Hill MD; Coutts SB; Gubitz G; Gelfer M; Vallée M; Prasad GV; Lebel M; McLean D; Arnold JM; Moe GW; Howlett JG; Boulanger JM; Larochelle P; Leiter LA; Jones C; Ogilvie RI; Woo V; Kaczorowski J; Burns KD; Petrella RJ; Hiremath S; Milot A; Stone JA; Drouin D; Lavoie KL; Lamarre-Cliche M; Tremblay G; Hamet P; Fodor G; Carruthers SG; Pylypchuk GB; Burgess E; Lewanczuk R; Dresser GK; Penner SB; Hegele RA; McFarlane PA; Khara M; Pipe A; Oh P; Selby P; Sharma M; Reid DJ; Tobe SW; Padwal RS; Poirier L;
    Can J Cardiol; 2014 May; 30(5):485-501. PubMed ID: 24786438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure guidelines - where are we now?
    Drug Ther Bull; 2008 Sep; 46(9):65-9. PubMed ID: 18784380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present-day treatment of arterial hypertension].
    Schuchert A
    Med Monatsschr Pharm; 2010 Dec; 33(12):462-8: quiz 469-70. PubMed ID: 21189521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic management of hypertension in patients with diabetes.
    Whalen KL; Stewart RD
    Am Fam Physician; 2008 Dec; 78(11):1277-82. PubMed ID: 19069021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
    Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Cléroux J; Feldman RD; Petrella RJ
    CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.